BuTrans in moderate chronic pain

BuTrans (buprenorphine) patches are now indicated in the management of non-malignant moderate chronic pain when an opioid is necessary for obtaining adequate analgesia.

The lowest strength (5 microgram/hr) patch should be used initially and the dose may be increased after three days; when the maximum effect of a given dose is established. The dose should be titrated according to the patient's analgesic response to the BuTrans patch and the need for supplemental pain relief.

View BuTrans drug record

Further information: Napp

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in